Key Takeaways
A chemical peel treatment record documents patient skin type, peel depth, solution used, application time, and post-care instructions – essential for safety and compliance.
Pre-treatment assessment must include contraindications (pregnancy, Fitzpatrick V-VI with TCA, active infections, isotretinoin use) to prevent adverse events.
Proper documentation supports regulatory compliance (CQC, GDPR, state cosmetology rules) and protects against liability.
Pabau’s digital forms and client records help aesthetic practices store, retrieve, and organize treatment records securely in one system.
Download your free chemical peel treatment record template
A ready-to-use treatment record template covering patient details, pre-treatment assessment, Fitzpatrick skin type classification, peel type and depth, product details, treatment notes, post-care instructions, and follow-up scheduling.
Download templateChemical peels are one of the most widely performed treatments in med spas and aesthetic practices, and dermatologists have safely performed them for more than 50 years, according to the American Academy of Dermatology.
Proper documentation — capturing patient skin type, peel depth, chemical concentration, timing, and post-care compliance — remains the foundation of safe practice and regulatory compliance. A chemical peel treatment record gives you clinical evidence that informed consent was obtained, contraindications were assessed, and the patient understood aftercare expectations.
This guide explains what belongs in a chemical peel treatment record, why documentation matters for your practice, and how to organize records digitally for compliance and quick retrieval.
What is a chemical peel treatment record?
A chemical peel treatment record is a comprehensive documentation tool that captures every clinical and operational detail of a chemical peel procedure — before, during, and after treatment. It serves three critical functions: Clinical evidence, regulatory protection, and patient safety.
The record documents the patient’s baseline skin condition, the specific peel type and chemical used, application technique and timing, observed skin response, and detailed aftercare instructions given. It also tracks whether consent was obtained, contraindications were ruled out, and the patient acknowledged post-treatment expectations.
In England, standalone chemical peels currently fall outside the Care Quality Commission’s (CQC) regulated activities. CQC oversight covers surgical or invasive cosmetic procedures — those involving a cut to the body or inserted equipment — not topical treatments like peels.
That doesn’t remove the documentation requirement. Practices still need records that meet UK GDPR and Data Protection Act standards, alongside the guidance set by professional bodies like the Joint Council for Cosmetic Practitioners (JCCP) and Save Face.
A proposed government licensing framework may eventually bring higher-risk, deeper peels into scope, though that would be a separate licensing scheme, not CQC registration.
In the US, state cosmetology licensing boards (e.g., Oregon OAR 817-015-0065) mandate chemical peel documentation that includes pre-treatment, treatment, and post-care details.
Why documentation matters for chemical peel treatments
Chemical peels carry specific risks: Hyperpigmentation, hypopigmentation, scarring, infection, and in deep peels, systemic toxicity. A thorough consultation process identifies which patients should not have a peel, and a detailed treatment record proves that assessment took place.
Documentation also protects your practice during a regulatory inspection or liability claim. Keeping client records current with treatment details, skin reactions, and follow-up notes demonstrates professional care and informed decision-making. Without clear records, a negative outcome becomes harder to defend.
Beyond legal protection, records enable better clinical outcomes: You can track which peel depths and concentrations work best for different skin types, identify patterns in healing time, and adjust treatment plans for repeat clients based on their previous response.
What to include in a chemical peel treatment record
A complete chemical peel treatment record should contain these sections:
Pre-treatment assessment and contraindications
Document the patient’s skin type using the Fitzpatrick scale (I-VI), baseline skin condition, and relevant history: Current skincare routine, sun exposure, previous peels, active infections, pregnancy status, and current medications (especially isotretinoin/Accutane). Record any absolute contraindications (active herpes, open wounds, recent ablative laser) and relative contraindications (darker skin types with deep phenol peels, eczema, rosacea) that the patient acknowledged understanding.
Peel type and chemical details
Specify the exact chemical used (glycolic acid, salicylic acid, TCA, phenol, etc.), its concentration (e.g., glycolic 30%, salicylic 20%), and the peel depth: Superficial (affects epidermis only), medium-depth (penetrates dermal-epidermal junction), or deep (reaches mid-dermis). Record brand names if applicable (e.g., BioRepeel, ZO 3 Step Peel) and lot/batch numbers for traceability.
Treatment application notes
Document the exact time the chemical was applied, how long it remained on skin, neutralization method, and any adjuncts used (numbing, cooling, topical anesthesia). Note whether a pre-treatment patch test was performed and the result. Record observed skin response during application (redness, frosting pattern, patient comfort level).
Immediate post-treatment care given
Record what post-care products were applied immediately after the peel (moisturizer, sunscreen, healing balm), any dressings used, and written aftercare instructions provided. An Alastin aftercare template shows the level of detail worth adapting for peels. Document the patient’s skin appearance post-treatment (redness, swelling, peeling onset) and any immediate adverse reactions observed.
Follow-up and consent acknowledgment
Note the scheduled follow-up date (typically 1 week for superficial peels, 2-3 weeks for medium peels) and whether the patient verbally confirmed understanding of healing timelines. A patient booking form can capture that date directly at checkout. Record that informed consent was signed before the procedure.
Pre-treatment assessment: Skin type and contraindications
The Fitzpatrick scale is the gold standard for assessing how skin will respond to chemical peels. Darker skin types (V and VI) are at higher risk for post-inflammatory hyperpigmentation and require gentler, shorter peel times and lower chemical concentrations.
TCA and phenol peels carry significant risk in Fitzpatrick V-VI, so practices often choose superficial glycolic or salicylic peels for these skin types instead.
Personalized treatment planning begins with documenting baseline skin texture, visible sun damage (actinic keratosis), acne scarring, melasma, or hyperpigmentation — these all shape which peel depth is appropriate. Absolute contraindications (current isotretinoin use, active cold sore, infected skin, pregnancy) must be recorded and acknowledged. Relative contraindications (eczema, rosacea, very sensitive skin) require clear notation of informed consent.
Chemical peel types and recovery timelines
Your record should note which peel depth was chosen and why. Superficial peels (glycolic 30-50%, salicylic 20%) can be repeated every 2-5 weeks with minimal downtime — about a week of erythema and light peeling.
Medium-depth peels (TCA 15-35%, glycolic 70%) require 6-12 month intervals between treatments and involve 7-10 days of visible peeling and erythema. Deep peels (phenol, TCA 35%+) are typically one-time treatments, needing 2-4 weeks of recovery and 6-8 weeks of pretreatment skin conditioning beforehand.
The same tracking habits apply to other resurfacing treatments, including microneedling aftercare protocols, where recovery timelines also need clear records.
Post-treatment care instructions and follow-up
Your record must include the specific aftercare instructions given to the patient. Patient compliance and follow-up directly affect outcomes: Improper aftercare increases hyperpigmentation, scarring, and infection risk. Document what you recommended (gentle cleanser, hydrating moisturizer, broad-spectrum SPF 30+, avoidance of active ingredients for 1-2 weeks post-peel, no swimming or intense exercise for 48 hours).
Record the follow-up appointment scheduled with the patient and whether they confirmed attendance. If a patient did not attend follow-up, note this and any communication attempts made to check on healing.
Documentation best practices for chemical peel records
Use consistent terminology. Document peel depth by the actual chemical and concentration, not vague terms like “light” or “medium.” Include date, time, and practitioner name. Before-and-after photo documentation is powerful evidence of treatment efficacy and patient consent. Ensure photos are labeled with the patient’s initials, date, and area treated (not the full face if privacy is a concern).
Store records securely and use paperless treatment records that are encrypted and backed up regularly. Digital systems allow rapid retrieval during follow-up visits or regulatory inspection and reduce the risk of physical records being lost or damaged.
Compliance and regulatory context
In the UK, standalone chemical peels aren’t a CQC-regulated activity, so the record-keeping obligation comes from data protection law and professional-body standards rather than CQC registration.
Data protection compliance under UK GDPR means records must be stored securely, accessible only to authorized staff, and retained only as long as clinically and legally necessary — commonly 8 years post-treatment, based on NHS records management guidance that private practices widely follow as best practice.
In the US, state-specific cosmetology regulations vary. Oregon’s OAR 817-015-0065, for example, requires cosmetologists to maintain records documenting the chemical used, concentration, application time, and client signature confirming informed consent. Many states recommend 3-7 year retention periods.
Medical documentation forms should be reviewed annually to ensure they meet current regulatory standards in your jurisdiction.
Storing and organizing chemical peel records digitally
Paper records are cumbersome and easily misfiled. Moving to digital consent forms and structured client record storage speeds up retrieval, ensures consistency, and supports compliance audits. Practice management systems like Pabau allow you to attach photos, notes, and follow-up reminders to each client’s record, creating a complete treatment history viewable at a glance.

Skin clinic workflows benefit from systems that automate post-treatment reminder messages (SMS, email) to ensure patients understand aftercare and attend follow-ups. Digital records also generate reports showing treatment frequency, outcomes by peel type, and patient satisfaction — data that helps refine your service offerings.
Common documentation mistakes to avoid
Never skip contraindication screening. Documenting “no contraindications” without actually asking about pregnancy, medications, or previous adverse reactions is negligent and indefensible if a complication arises.
Do not use vague peel descriptions (“mild peel,” “standard peel”). Always specify the chemical, concentration, and depth so future practitioners understand exactly what was done.
Avoid handwritten notes that are illegible or incomplete. Digital records enforce consistency and are easier for regulatory bodies to review. Record times and dates precisely. “Peel applied at 2:15 PM for 8 minutes” is far better than “applied for a few minutes.”
Never discard records prematurely. Most jurisdictions expect 3-7 year retention, and destroying records early can be interpreted as evidence destruction if a dispute later arises.
Conclusion
A chemical peel treatment record only earns its keep if it captures the details that matter: Fitzpatrick skin type, the exact chemical and concentration used, contraindications ruled out, and the aftercare instructions given. Skipping any of these leaves a practice exposed if a patient has a reaction or a regulator asks questions.
Whether you’re documenting for UK data protection standards, US state cosmetology rules, or your own quality-control process, the same principle applies: Specific, dated, legible records protect the patient and the practice.
Digitizing that record — with photos, notes, and follow-up reminders attached to each client’s file — makes it easier to keep that standard consistent across every peel you perform.
Frequently Asked Questions
A complete chemical peel treatment record includes patient skin type (Fitzpatrick scale), baseline skin condition, contraindications screened, the exact chemical used and concentration, peel depth, application time, neutralization method, observed skin response, immediate post-care products applied, written aftercare instructions, scheduled follow-up date, and confirmation that informed consent was obtained.
Record retention periods vary by jurisdiction. In the UK, private practices commonly follow an 8-year post-treatment standard, based on NHS records management guidance, since standalone chemical peels aren’t a CQC-regulated activity. In the US, state cosmetology rules typically require 3-7 years. Check your professional body (e.g., JCCP, Save Face) or state health board for the specific requirement that applies to you.
The Fitzpatrick scale (I-VI) predicts how skin will respond to peeling agents. Darker skin types (V-VI) are at higher risk for post-inflammatory hyperpigmentation and require gentler peels, lower concentrations, and shorter application times. Documenting skin type ensures the practitioner chose an appropriate peel depth and informs follow-up risk counseling.
Absolute contraindications (record and decline the procedure) include current isotretinoin use, active cold sores or oral herpes, open wounds, infected skin, and pregnancy. Relative contraindications (document and obtain informed consent) include eczema, rosacea, very sensitive skin, and darker skin types with deep peels. Always record which were assessed and the patient’s acknowledgment.
Yes. Informed consent must document that the patient understands the peel type, expected recovery time, potential risks (hyperpigmentation, scarring, infection), and aftercare requirements. Your record should confirm the patient signed consent and verbally acknowledged understanding. This protects your practice and demonstrates ethical practice.